Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Lincoln Leaves Incyte, Heads to Informax

NEW YORK, Nov 21 – In a coup for Informax, leading bioinformaticist Stephen Lincoln has resigned from Incyte Genomics as vice president of bioinformatics research and development to take a job with the Rockville, Md.-based company, Informax CEO Alex Titomirov said Tuesday.

“He will be developing strategies and be involved in product development at the company,” said Titomirov.

Lincoln, who will technically begin his new job in December, has been named senior vice president of life sciences, bioinformatics, and will report to COO Jim Bernstein. According to sources, Lincoln has already been putting time in at Informax.

Incyte did not offer any information on Lincoln’s replacement.

Titomirov declined to say whether Lincoln would continue working on data integration platform development, which was one of his last projects at Incyte. Lincoln had been closely involved with Incyte’s new Genomics Knowledge Platform.

Titomirov said more details would be released when Informax officially makes an announcement about the company’s latest hire.

Industry observers speculated that Lincoln was being brought in to lead a new project. Lincoln, who worked at Incyte for five years, declined to comment about his new job.

Lincoln’s connections in the industry are expected to be especially valuable for Informax. Lincoln studied under Eric Lander at MIT’s Whitehead Institute and is considered a big name in the genomics industry.

Hiring Lincoln will certainly help bolster Informax’s Linux expertise. Lincoln, 36, was an early supporter of open source computing and pushed for Incyte to build its Linux-based compute farm.

Incyte uses the cluster of 3,600 processors in more than 1,200 boxes for multiple purposes including production, mining, and quality control of data.

On Tuesday Incyte announced that it had teamed up with SGI to install a similar Linux cluster at Bristol-Myers Squibb.

Bristol-Myers is the first user for the Incyte-SGI system, which links Incyte's Linux cluster with an SGI Origin 2000 server.
The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.